Questions: Parathyroid Hormone and Calcium-Phosphate Homeostasis

Question 1

A patient with a PTH-secreting parathyroid adenoma has elevated serum calcium but unexpectedly low serum phosphate. A medical student is puzzled: 'If PTH drives bone resorption, shouldn't both calcium AND phosphate be elevated?' What is the correct explanation?

• A. The adenoma secretes an abnormal PTH isoform that selectively mobilizes calcium from bone without releasing phosphate
• B. PTH simultaneously increases renal phosphate excretion at the proximal tubule, so despite releasing phosphate from bone, the net serum effect is low phosphate — excess is excreted in urine
• C. The patient's kidneys are failing independently, causing excess phosphate elimination unrelated to PTH
• D. Bone resorption releases calcium but not phosphate, because these minerals are stored in separate compartments within bone matrix

Answer: (B)

Bone mineral (hydroxyapatite) contains both calcium and phosphate in approximately fixed proportions, so osteoclast-driven bone resorption releases both ions into the blood. The key is what happens next: PTH simultaneously acts on the proximal tubule to *decrease* phosphate reabsorption, promoting phosphate excretion in the urine. This is by design — if both calcium and phosphate rose together, they could precipitate as calcium-phosphate crystals in soft tissues, kidneys, and blood vessels. PTH's renal phosphaturia ensures that the calcium rise from bone resorption is not accompanied by a parallel phosphate rise, protecting against ectopic calcification. This is why classic primary hyperparathyroidism produces the combination of hypercalcemia AND hypophosphatemia.

Question 2

Through what sequence of events does PTH increase intestinal calcium absorption?

• A. PTH binds directly to receptors on intestinal epithelial cells and upregulates calcium transport proteins within minutes
• B. PTH stimulates renal 1α-hydroxylase to convert 25-hydroxyvitamin D into active calcitriol (1,25-dihydroxyvitamin D₃), which then travels to the intestine and increases calcium absorption
• C. PTH signals through the enteric nervous system, activating calcium-permeable channels in intestinal enterocytes
• D. PTH stimulates osteoblasts to release IGF-1, which travels to the intestine and upregulates calcium transport

Answer: (B)

PTH does not directly act on the intestine — there are no significant PTH receptors on intestinal epithelial cells. Instead, PTH acts on the kidney: it stimulates the enzyme 1α-hydroxylase in the proximal tubular cells to convert 25-hydroxyvitamin D (the inactive circulating storage form produced by the liver) into 1,25-dihydroxyvitamin D₃ (calcitriol), the active hormone. Calcitriol then circulates to the small intestine, where it acts as a nuclear receptor ligand to upregulate calcium and phosphate transport proteins. This indirect pathway is slower (hours to days) than PTH's direct effects on bone and kidney (minutes to hours) but provides sustained enhancement of calcium supply from dietary sources.

Question 3

The parathyroid glands require a signal from the pituitary gland to begin secreting PTH when blood calcium falls, making calcium homeostasis part of the hypothalamic-pituitary axis.

• T. True
• F. False

Answer: False

This is a common error arising from overgeneralizing the hypothalamic-pituitary axis, which governs many endocrine systems (thyroid, adrenal, gonads). Parathyroid hormone regulation operates by a completely different, more direct mechanism. The parathyroid chief cells express calcium-sensing receptors (CaSR) directly on their surface, which continuously monitor blood calcium concentration and directly suppress or stimulate PTH secretion in response. No hypothalamic or pituitary signal is involved — the parathyroid glands are autonomous sensors and responders. This makes PTH regulation among the fastest endocrine responses in the body: PTH can be released from pre-formed granules within seconds of a drop in calcium.

Question 4

PTH raises blood calcium while simultaneously promoting renal phosphate excretion, preventing the rise in serum phosphate that would otherwise accompany bone resorption and risk precipitating calcium-phosphate crystals in soft tissues.

• T. True
• F. False

Answer: True

This is the elegant coordination at the heart of PTH's design. Bone resorption by osteoclasts releases both calcium and phosphate from hydroxyapatite. If both accumulated in the blood at the same time, the calcium-phosphate ion product could exceed the solubility limit, causing calcium-phosphate precipitation in kidneys, blood vessels, and soft tissues — exactly the complications seen in chronic kidney disease where phosphate clearance fails. PTH forestalls this by stimulating phosphaturia (phosphate excretion) in the proximal tubule while simultaneously stimulating calcium reabsorption in the distal tubule. Calcium goes up; phosphate goes down. This reciprocal regulation is not incidental but a designed feature of the PTH response.

Question 5

PTH mobilizes calcium through coordinated actions at three organs. Briefly describe each organ's contribution, and explain why this multi-pronged approach is more effective than any single mechanism alone.

Model answer: Bone: PTH stimulates osteoblasts to express RANKL, which activates osteoclasts to resorb bone matrix and release stored calcium into the blood — providing a large, immediate reservoir. Kidney (distal tubule): PTH increases calcium reabsorption, reducing urinary calcium losses — conserving what is already in the blood. Kidney (proximal tubule → vitamin D activation): PTH stimulates 1α-hydroxylase to produce active calcitriol, which acts on the intestine to increase dietary calcium absorption — providing a sustained supply. Each mechanism operates on a different timescale and source: bone provides rapid mobilization, renal conservation prevents ongoing losses, and intestinal absorption provides long-term replenishment. No single mechanism is sufficient alone — mobilizing calcium from bone indefinitely would cause catastrophic bone loss; renal conservation alone provides no new calcium; intestinal absorption alone is too slow for acute hypocalcemia. The combination of all three ensures rapid correction with long-term sustainability.

The multi-organ architecture also provides resilience: if one mechanism is impaired (e.g., vitamin D deficiency reduces intestinal absorption), the others compensate. This redundancy is why calcium homeostasis is so robust under normal conditions — and why understanding all three mechanisms is necessary to diagnose disorders like hypoparathyroidism, vitamin D deficiency, and primary hyperparathyroidism, which affect different parts of this system.